Celonic Group, a leading Swiss-based contract development and manufacturing organisation (CDMO), has integrated Merck’s Breez™ micro-bioreactor platform into its process development workflow.

The sustainability of bioprocessing depends on many decisions and technologies. Sustainability and other factors must be in ...

A public open house was held in Miami Tuesday evening for a controversial facility that would use chicken waste to produce a ...

The Breez 2 mL micro-bioreactor platform is a fully automated, functionally closed, and continuous perfusion cell culture ...

Repligen (RGEN) and 908 Devices (MASS) announced that Repligen has purchased 908 Devices’ desktop portfolio of four devices for bioprocessing ...

The global market for single-use bioprocessing probes and sensors is experiencing a robust growth trajectory, driven by ...

Repligen has acquired 908 Devices' desktop portfolio of four devices for bioprocessing process analytical technology applications for $70 million in cash.

Celonic Group, a Swiss-Based Quality CDMO, is integrating Merck’s Breez micro-bioreactor platform into its process ...

The company’s portfolio includes a wide range of products and services, from bioprocessing equipment and consumables to diagnostic tools and environmental testing solutions. As a prominent ...

WALTHAM, Mass. and BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc ...

Repligen Corporation has acquired 908 Devices' desktop portfolio, which includes four analytical devices for bioprocessing applications, for $70 million in cash. This acquisition enhances Repligen ...